Abstract:Background: Asia consists of diverse nations with extremely variable health care systems. Integrated real-world data (RWD) research warehouses provide vast interconnected data sets that uphold statistical rigor. Yet, their intricate details remain underexplored, restricting their broader applications. Objective: Building on our previous research that analyzed integrated RWD warehouses in India, Thailand, and Taiwan, this study extends the research to 7 distinct health care systems: Hong Kong, Indonesia, Malaysia, Pakistan, the Philippines, Singapore, and Vietnam. We aimed to map the evolving landscape of RWD, preferences for methodologies, and database use and archetype the health systems based on existing intrinsic capability for RWD generation. Methods: A systematic scoping review methodology was used, centering on contemporary English literature on PubMed (search date: May 9, 2023). Rigorous screening as defined by eligibility criteria identified RWD studies from multiple health care facilities in at least 1 of the 7 target Asian nations. Point estimates and their associated errors were determined for the data collected from eligible studies. Results: Of the 1483 real-world evidence citations identified on May 9, 2023, a total of 369 (24.9%) fulfilled the requirements for data extraction and subsequent analysis. Singapore, Hong Kong, and Malaysia contributed to ≥100 publications, with each country marked by a higher proportion of single-country studies at 51% (80/157), 66.2% (86/130), and 50% (50/100), respectively, and were classified as solo scholars . Indonesia, Pakistan, Vietnam, and the Philippines had fewer publications and a higher proportion of cross-country collaboration studies (CCCSs) at 79% (26/33), 58% (18/31), 74% (20/27), and 86% (19/22), respectively, and were classified as global collaborators . Collaboration with countries outside the 7 target nations appeared in 84.2% to 97.7% of the CCCSs of each nation. Among target nations, Singapore and Malaysia emerged as preferred research partners for other nations. From 2018 to 2023, most nations showed an increasing trend in study numbers, with Vietnam (24.5%) and Pakistan (21.2%) leading the growth; the only exception was the Philippines, which declined by –14.5%. Clinical registry databases were predominant across all CCCSs from every target nation. For single-country studies, Indonesia, Malaysia, and the Philippines favored clinical registries; Singapore had a balanced use of clinical registries and electronic medical or health records, whereas Hong Kong, Pakistan, and Vietnam leaned toward electronic medical or health records. Overall, 89.9% (310/345) of the studies took >2 years from completion to publication. Conclusions: The observed variations in contemporary RWD publications across the 7 nations in Asia exemplify distinct research landscapes across nations that are partially explained by their diverse economic, clinical, and research settings. Nevertheless, recognizing these variations is pivotal for fostering tailored, synergistic strategies that amplify RWD's potential in guiding future health care research and policy decisions.

Existing barriers and recommendations of real-world data standardisation for clinical research in China: a qualitative study

Advancing the development of real-world data for healthcare research in China: challenges and opportunities

Gap between real-world data and clinical research within hospitals in China: a qualitative study

Barriers and Facilitators to Data Quality of Electronic Health Records Used for Clinical Research in China: a Qualitative Study

Real-World Data for Healthcare Research in China: Call for Actions.

The Use of Real‐World Evidence for Regulatory Decisions in China

Real-World Big-Data Studies In Laboratory Medicine: Current Status, Application, And Future Considerations

Toward a Better Understanding about Real-World Evidence

Preliminary Assessment of the Data Appropriateness of Electronic Health Records for Real-World Studies: A Survey of Hospitals in a Developing Region in China

Use of Real-World Evidence for Drug Regulatory Decisions in China: Current Status and Future Directions

[Methodology progress and challenges on assessing the appropriateness of real-world data]

Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings.

On standardization of basic datasets of electronic medical records in traditional Chinese medicine

[Progress in methodological research on bridging the efficacy-effectiveness gap of clinical interventions (1): to improve the validity of real-world evidence]

Use of Real-World Evidence to Support Regulatory Decisions on Medical Devices in China and a Unique Opportunity to Gain Accelerated Approval in "boao Lecheng Pilot Zone".

[Real-World Data Studies of Medical Products in the Context of Special Healthcare Policy: Study Designs and Key Considerations].

Real-World Data and Real-World Evidence in Healthcare in the United States and Europe Union

Contemporary Practice and Considerations for Real-World Data Source Identification and Feasibility Assessment

Integrated Real-World Study Databases in 3 Diverse Asian Health Care Systems in Taiwan, India, and Thailand: Scoping Review

Integrated Real-World Data Warehouses Across 7 Evolving Asian Health Care Systems: Scoping Review

Utilization of real-world evidence in clinical research of medical devices